Dr. Satheesh CT

Medical Oncology

Oncology

HCG Cancer Centre, K R Road - Bangalore, India

Book Appointment

Visa Invitation Letter

Treatment Estimate

Qualification

MBBS, MD (Paediatrics), DM (Medical Oncology), ESMO (European Society of Medical Oncology), FRCP (Edin)

Languages

English Hindi Kannada Telugu

Work Experience

15 Years

Research Experience

• FDG-PET Metabolic Vs CT Anatomical Monitoring of Tumour Response to Anterior Chemotherapy in Breast Carcinoma-The Uncertainties. Canc Therapy & Oncol Int J. 2021; 19(1): 556003.
• Landscape of clinically actionable mutations in breast cancer 'A cohort study'. Transl Oncol. 2021 Jan;14(1):100877.
• Translational relevance of baseline peripheral blood biomarkers to assess the efficacy of anti-programmed cell death 1 use in solid malignancies. J Cancer Res Ther. 2021 Jan-Mar;17(1):114-121.
• The future of lung cancer therapy: Striding beyond conventional EGFR and ALK treatments. Mol Clin Oncol. 2019 Apr;10(4):469-475.
• Intraperitoneal bevacizumab (Bev) for control of refractory malignant ascites. A single centre experience. Annals of Oncology 27 (Supplement 6): vi455–vi461
2016.
• Genomic Profiling in Non-Small Cell Lung Cancer: New Hope for Personalized Medicine.
• Journal of Thoracic Oncology
Vol. 12
Issue 1
S974–S975: January 2017.
• Indian experience of Lenvatinib in radio-iodine refractory differentiated thyroid cancer.
• May 2018 Journal of Clinical Oncology 36(15_suppl) :e18107-e18107.
• Landscape of clinically actionable mutations in breast cancer ‘A cohort study’. January 2021
Translational Oncology 14(1):100877

Awards & Achivements

He also received extensive training in the essentials of palliative care and clinical placement in palliative care from IAPC.

Memberships

Dr. Satheesh CT is a member of the following professional organizations:
o European Society of Medical Oncology (ESMO)
o Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin)
o Indian Society of Medical Oncology (ISMO)
o Karnataka Oncology Society (KOS)
o Indian Cooperative Oncology Network (ICON)
o Association of Radiation Oncologists of India (AROI)

Area of Interest

• Dr. Satheesh is a consultant – in medical and heamato oncology and the director of clinical trials at HCG Cancer Centre
Bengaluru.
• Dr. Satheesh’s key areas of experience include the treatment of various solid and hematological cancers with conventio

Dr. Satheesh is an esteemed consultant in Medical and Haemato Oncology and the Director of Clinical Trials at the HCG Cancer Centre in Bengaluru. His expertise lies in the treatment of various solid and haematological cancers with conventional, high-dose chemotherapy, targeted chemotherapy, and immunotherapy, as well as paediatric malignancies, lymphomas, gynaecological cancers, breast and lung cancers, and cancer genomics. Dr. Satheesh has also received extensive training in the essentials of palliative care from the IAPC. With a patient-centric approach, he provides compassionate and comprehensive care to all his patients.